MedCity News
JULY 2, 2023
New research predicts that healthcare costs will increase by 7% next year. The estimate is higher than the projected medical cost trends in 2022 and 2023 — which were 5.5% and 6.0%, respectively.
PharmaTech
JULY 2, 2023
Manufacturers face the challenge of meeting growing demand for personalized biopharmaceuticals.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JULY 2, 2023
Implementing a specialty pharmacy strategy and approach for growth not only creates a revenue stream for the system, but also establishes a high-touch patient engagement program that becomes a differentiator in the way service is delivered for their community.
PharmExec
JULY 2, 2023
Here in New Jersey, our home base, summer is officially upon us, and the Canadian wildfire smoke has just cleared from the air. I’m sure the bird watchers would attest to the eager chirping as both wildlife and humans greedily enjoy the beautiful weather. But even as the seasons change, so does the technology that drives innovation, as coverage in the July issue of Pharmaceutical Executive® attests.
MedCity News
JULY 2, 2023
CellTrans’s Lantidra is now the first FDA-approved cell therapy for type 1 diabetes. The therapy is made from islet cells sourced from deceased donors.
PharmaTech
JULY 2, 2023
To overcome the challenges of the widening range and scope of products that require aseptic processing and the evolving regulatory landscape in this field, companies should deepen their knowledge base on best practices.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
PharmaTech
JULY 2, 2023
FDA’s new guidance on in-vitro permeation test studies published in October 2022 gives technical and statistical requirements for conducting these tests to compare topical generic drugs with their reference products.
MedCity News
JULY 2, 2023
Progyny is now a “preferred partner” on Quantum’s Comprehensive Care Solutions platform, which is a group of benefits solutions that Quantum’s more than 500 employer clients can choose to work with.
PharmaTech
JULY 2, 2023
Detection of nitrosamines in several commercial drugs has resulted in manufacturing batch recalls followed by a review of the APIs’ synthesis processes by MAHs.
PharmExec
JULY 2, 2023
Click the title above for a link to open the Pharmaceutical Executive June 2023 issue in an interactive PDF format.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
PharmaTech
JULY 2, 2023
The degree of formality in a risk management process should be customized to the organization’s particular needs and the risks involved.
PharmaTech
JULY 2, 2023
FDA Warning Letters and Form 483s can offer a path to better compliance, says Siegfried Schmitt, vice president, Technical, at Parexel.
PharmaTech
JULY 2, 2023
Sample dilution, sensitivity, excipient interference, and containment are key issues that must be addressed.
PharmaTech
JULY 2, 2023
Preparation is essential for regulatory meetings—it not only crystallizes what is needed from the regulators, it helps them better understand the development programme and potential challenges.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmaTech
JULY 2, 2023
Problems continue despite actions by regulators to better prevent and address drug shortages.
PharmaTech
JULY 2, 2023
Data from environmental monitoring can assist in keeping sterile environments sterile.
PharmaTech
JULY 2, 2023
If we view a change opposite of one’s interest as antithetical to innovation, we risk losing sight of our ultimate goal.
PharmaTech
JULY 2, 2023
The UK and EU have negotiated a new draft deal for Britain to re-join the Horizon Europe research programme.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaTech
JULY 2, 2023
Changes to PRIME scheme are set to drive greater harmonization across major pharmaceutical markets.
PharmaTech
JULY 2, 2023
The debate surrounding drug pricing changes rages on.
PharmaTech
JULY 2, 2023
Automation can be balanced with operator oversight.
Expert insights. Personalized for you.
105 
Let's personalize your content